NCT07405424 Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
| NCT ID | NCT07405424 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Leukemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-06-20 |
| Primary Completion | 2028-06-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-06-20 with a primary completion date of 2028-06-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.
Eligibility Criteria
Inclusion criteria * Adults (18 years or older) * Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy * Ability to read, understand, and speak the English language * Ability to understand and the willingness to sign a written informed consent document Exclusion criteria * Unable to comply with spiritual care intervention * Relapsed or refractory acute leukemia * Cognitive deficits that limit participation and survey questionnaire completion
Contact & Investigator
Wendy Stock
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT07405424 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Leukemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07405424 currently recruiting?
Yes, NCT07405424 is actively recruiting participants. Contact the research team at cancerclinicaltrials@bsd.uchicago.edu for enrollment information.
Where is the NCT07405424 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07405424 clinical trial?
NCT07405424 is sponsored by University of Chicago. The principal investigator is Wendy Stock at University of Chicago. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.